Amgen's growth engine and Pfizer's value appeal pull in opposite directions, and the valuation gap between them is wider than ...

The study tracked 544,103 adults with prior statin use over a period of up to four years in routine clinical care.

Amgen's Imdelltra has shown that it can significantly reduce the risk of death in patients who have extensive-stage small ...

By Deena Beasley Nov 3 (Reuters) - Amgen on Tuesday said third-quarter sales rose 8%, led by demand for cholesterol drug ...

Operator: My name is Julianne, and I will be your conference facilitator today for the Amgen Q3 2026 Earnings Conference Call ...

Amgen (NasdaqGS:AMGN) announced a new collaboration with the National Organization for Rare Disorders to speed rare ...

With the first Phase 3 data expected for Amgen’s MariTide next year, analysts are looking for evidence that the GLP-1 ...

Novartis has lifted the lid on data from its failed cardiovascular outcomes trial, reporting a total absence of efficacy that ...

The FDA warned Amgen that a submitted promotional video for its colorectal cancer drug Vectibix was misleading because it ...

Amgen appears safe, but the current valuation above $450/share may prove expensive by Q3 2026. Click here to read an analysis of AMGN stock now.

Oct 20 (Reuters) - Amgen and AstraZeneca said on Tuesday their asthma drug helped reduce swallowing difficulties and achieved disease remission in 69% of patients with a type of chronic inflammatory ...

Biopharma industry veteran Jackie Elbonne, Ph.D., is retiring at the end of the year, leaving Amgen’s top quality spot to her ...